SEC Form D private-offering filing

Kamal Therapeutics, Inc.

Name: Kamal Therapeutics, Inc. - new SEC Form D private-offering filing, Hingham, MA
Published: 2025-11-24

A new SEC Form D private-offering notice from Hingham, MA, a $17,307,138 filer-stated offering target in Biotech. The source filing is one click away.

Kamal Therapeutics, Inc. site↗ Verified via SEC Form D

Developing an intravenous recombinant human decorin therapy to treat dystrophic epidermolysis bullosa, a rare genetic skin blistering disorder.

Filed 2025-11-24Filed to raise $17,307,138First money in 2025-11-10Raised so far $13,807,138HQ (as filed) Hingham, MASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified kamaltherapeutics.com↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.